88 related articles for article (PubMed ID: 19855245)
21. Combined treatment with chemokine receptor 5 blocker and cyclosporine induces prolonged graft survival in a mouse model of cardiac transplantation.
Jun L; Kailun Z; Aini X; Lei X; Guohua W; Sihua W; Ping Y; Tucheng S; Xionggang J; Wenwei C; Jiahong X
J Heart Lung Transplant; 2010 Apr; 29(4):461-70. PubMed ID: 20060322
[TBL] [Abstract][Full Text] [Related]
22. HIV entry inhibitor TAK-779 attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
van Wanrooij EJ; Happé H; Hauer AD; de Vos P; Imanishi T; Fujiwara H; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2642-7. PubMed ID: 16239591
[TBL] [Abstract][Full Text] [Related]
23. TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice.
Takami S; Minami M; Katayama T; Nagata I; Namura S; Satoh M
J Cereb Blood Flow Metab; 2002 Jul; 22(7):780-4. PubMed ID: 12142563
[TBL] [Abstract][Full Text] [Related]
24. Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety.
Shiraishi M; Aramaki Y; Seto M; Imoto H; Nishikawa Y; Kanzaki N; Okamoto M; Sawada H; Nishimura O; Baba M; Fujino M
J Med Chem; 2000 May; 43(10):2049-63. PubMed ID: 10821717
[TBL] [Abstract][Full Text] [Related]
25. Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors.
Verzijl D; Storelli S; Scholten DJ; Bosch L; Reinhart TA; Streblow DN; Tensen CP; Fitzsimons CP; Zaman GJ; Pease JE; de Esch IJ; Smit MJ; Leurs R
J Pharmacol Exp Ther; 2008 May; 325(2):544-55. PubMed ID: 18270317
[TBL] [Abstract][Full Text] [Related]
26. CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice.
Li J; Zhang K; Ye P; Wang S; Xia J
Clin Exp Immunol; 2009 Sep; 157(3):437-45. PubMed ID: 19664153
[TBL] [Abstract][Full Text] [Related]
27. Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy.
Yun JJ; Fischbein MP; Laks H; Fishbein MC; Espejo ML; Ebrahimi K; Irie Y; Berliner J; Ardehali A
Transplantation; 2000 Jun; 69(12):2515-24. PubMed ID: 10910271
[TBL] [Abstract][Full Text] [Related]
28. The blocking of CXCR3 and CCR5 suppresses the infiltration of T lymphocytes in rat renal ischemia reperfusion.
Tsutahara K; Okumi M; Kakuta Y; Abe T; Yazawa K; Miyagawa S; Matsunami K; Otsuka H; Kaimori J; Takahara S; Nonomura N
Nephrol Dial Transplant; 2012 Oct; 27(10):3799-806. PubMed ID: 22904101
[TBL] [Abstract][Full Text] [Related]
29. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients.
Baker MS; Chen X; Rotramel AR; Nelson JJ; Lu B; Gerard C; Kanwar Y; Kaufman DB
Surgery; 2003 Aug; 134(2):126-33. PubMed ID: 12947308
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model.
Kimura N; Itoh S; Nakae S; Axtell RC; Velotta JB; Bos EJ; Merk DR; Gong Y; Okamura H; Nagamine CM; Adachi H; Kornfeld H; Robbins RC; Fischbein MP
J Heart Lung Transplant; 2011 Dec; 30(12):1409-17. PubMed ID: 22055099
[TBL] [Abstract][Full Text] [Related]
31. Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft.
Kwun J; Farris AB; Song H; Mahle WT; Burlingham WJ; Knechtle SJ
Transplantation; 2015 Dec; 99(12):2485-93. PubMed ID: 26102611
[TBL] [Abstract][Full Text] [Related]
32. A novel CCR5/CXCR3 antagonist protects intestinal ischemia/reperfusion injury.
Akahori T; Sho M; Kashizuka H; Nomi T; Kanehiro H; Nakajima Y
Transplant Proc; 2006 Dec; 38(10):3366-8. PubMed ID: 17175273
[TBL] [Abstract][Full Text] [Related]
33. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5.
Hall SE; Mao A; Nicolaidou V; Finelli M; Wise EL; Nedjai B; Kanjanapangka J; Harirchian P; Chen D; Selchau V; Ribeiro S; Schyler S; Pease JE; Horuk R; Vaidehi N
Mol Pharmacol; 2009 Jun; 75(6):1325-36. PubMed ID: 19297521
[TBL] [Abstract][Full Text] [Related]
34. Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer.
Tan MC; Goedegebuure PS; Belt BA; Flaherty B; Sankpal N; Gillanders WE; Eberlein TJ; Hsieh CS; Linehan DC
J Immunol; 2009 Feb; 182(3):1746-55. PubMed ID: 19155524
[TBL] [Abstract][Full Text] [Related]
35. Suppression of cardiac allograft vasculopathy in mice by inhibition of CC-motif chemokine receptor 5.
Bao C; Lv Z; Zhang X; Zhu J; Ding F; Zhang Y; Mei J
Transpl Immunol; 2012 Mar; 26(2-3):128-32. PubMed ID: 22154893
[TBL] [Abstract][Full Text] [Related]
36. Suppression of (5R)-5-hydroxytriptolide (LLDT-8) on allograft rejection in full MHC-mismatched mouse cardiac transplantation.
Tang W; Zhou R; Yang Y; Li YC; Yang YF; Zuo JP
Transplantation; 2006 Mar; 81(6):927-33. PubMed ID: 16570019
[TBL] [Abstract][Full Text] [Related]
37. CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779.
Nedjai B; Viney JM; Li H; Hull C; Anderson CA; Horie T; Horuk R; Vaidehi N; Pease JE
Br J Pharmacol; 2015 Apr; 172(7):1822-33. PubMed ID: 25425280
[TBL] [Abstract][Full Text] [Related]
38. Pioglitazone prevents acute and chronic cardiac allograft rejection.
Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
[TBL] [Abstract][Full Text] [Related]
39. Selective infiltration of CCR5(+)CXCR3(+) T lymphocytes in human colorectal carcinoma.
Musha H; Ohtani H; Mizoi T; Kinouchi M; Nakayama T; Shiiba K; Miyagawa K; Nagura H; Yoshie O; Sasaki I
Int J Cancer; 2005 Oct; 116(6):949-56. PubMed ID: 15856455
[TBL] [Abstract][Full Text] [Related]
40. I-TAC is a dominant chemokine in controlling skin intragraft inflammation via recruiting CXCR3+ cells into the graft.
Li B; Xu W; Xu L; Jiang Z; Wen Z; Li K; Xiong S
Cell Immunol; 2010; 260(2):83-91. PubMed ID: 19875106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
